Markus Zollinger
Impact in
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
- Molecular Biology top 5%
- Sphingolipid Metabolism and Signaling
- Lipid Membrane Structure and Behavior
- Inflammasome and immune disorders
Papers in
-
- Sphingolipid Metabolism and Signaling 4
-
- Pharmacogenetics and Drug Metabolism 4
- Co-authors
- Rainer Albert (2 shared papers)Volker Brinkmann (2 shared papers)Eva E. Prieschl (1 shared paper)Carolyn A. Foster (1 shared paper)Christopher E. Heise (1 shared paper)Robert Hof (1 shared paper)Michael D. Davis (1 shared paper)Peter Hiestand (1 shared paper)
- Journals
- Drug Metabolism and Disposition (9 papers)Journal of Neurochemistry (5 papers)Journal of Medicinal Chemistry (2 papers)Analytical Biochemistry (1 paper)Xenobiotica (1 paper)
- Partner nations
- SwitzerlandUnited StatesAustria
In The Last Decade
Markus Zollinger
31 papers receiving 2.4k citations
Markus Zollinger's Hit Papers
Peers
Comparison fields: 5 of 110
- Pharmacology 203
- Molecular Biology 1.5k
- Hematology 233
- Biochemistry 154
- Neurology 162
Countries citing papers authored by Markus Zollinger
This map shows the geographic impact of Markus Zollinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Zollinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Zollinger more than expected).
Fields of papers citing papers by Markus Zollinger
This network shows the impact of papers produced by Markus Zollinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Zollinger. The network helps show where Markus Zollinger may publish in the future.
Co-authors
The 25 scholars most cited alongside Markus Zollinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors Hit paper breakdown → | 2002 | 1283 |
| 2 | 2005 | 189 | |
| 3 | 1997 | 160 | |
| 4 | 2005 | 124 | |
| 5 | 1999 | 91 | |
| 6 | 1995 | 72 | |
| 7 | 1988 | 63 | |
| 8 | 2010 | 53 | |
| 9 | 2014 | 52 | |
| 10 | In vitro metabolism of tegaserod in human liver and intestine: assessment of drug interactions. | 2001 | 48 |
| 11 | 2010 | 41 | |
| 12 | 1992 | 37 | |
| 13 | 1994 | 32 | |
| 14 | 1993 | 29 | |
| 15 | 2006 | 29 | |
| 16 | 1989 | 27 | |
| 17 | 1989 | 27 | |
| 18 | 1985 | 20 | |
| 19 | 2007 | 20 | |
| 20 | 2016 | 19 |
About Markus Zollinger
Markus Zollinger is a scholar working on Molecular Biology, Pharmacology, Spectroscopy, Cellular and Molecular Neuroscience and Biochemistry, having authored 31 papers that have together received 2.5k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (5 papers), Sphingolipid Metabolism and Signaling (4 papers), Pharmacogenetics and Drug Metabolism (4 papers), Analytical Chemistry and Chromatography (4 papers), Mass Spectrometry Techniques and Applications (4 papers), Amino Acid Enzymes and Metabolism (3 papers), Plant and fungal interactions (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). The work is most often cited by research in Pharmacology (203 citations), Molecular Biology (1.5k citations), Hematology (233 citations), Biochemistry (154 citations) and Neurology (162 citations). Markus Zollinger has collaborated with scholars based in Switzerland, United States and Austria. Frequent co-authors include Rainer Albert, Volker Brinkmann, Eva E. Prieschl, Carolyn A. Foster, Christopher E. Heise, Robert Hof, Michael D. Davis, Peter Hiestand, Sylvain Cottens and Christian Bruns. Their work appears in journals such as Drug Metabolism and Disposition, Journal of Neurochemistry, Journal of Medicinal Chemistry, Analytical Biochemistry and Xenobiotica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.